22-Jul-2026
PetMed enters $37M sale-leaseback deal for Florida headquarters
Seeking Alpha News (Thu, 23-Jul 8:29 AM ET)
Globe Newswire (Thu, 23-Jul 8:00 AM ET)
PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform
Globe Newswire (Tue, 14-Jul 8:00 AM ET)
Market Chameleon (Tue, 30-Jun 6:33 AM ET)
Globe Newswire (Tue, 30-Jun 9:15 AM ET)
Market Chameleon (Mon, 29-Jun 5:52 AM ET)
SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash
Globe Newswire (Mon, 29-Jun 7:08 AM ET)
PetMeds Announces Fourth Quarter and Fiscal Year 2026 Financial Results
Globe Newswire (Tue, 2-Jun 4:05 PM ET)
Globe Newswire (Fri, 29-May 8:00 AM ET)
PetMeds Unveils Wellness-Focused Holiday Collection Aimed at Health-Conscious Pet Parents
Market Chameleon (Thu, 11-Dec 4:53 AM ET)
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
Petmed Express trades on the NASDAQ stock market under the symbol PETS.
As of July 22, 2026, PETS stock price declined to $1.96 with 28,785 million shares trading.
PETS has a beta of 1.63, meaning it tends to be more sensitive to market movements. PETS has a correlation of 0.05 to the broad based SPY ETF.
PETS has a market cap of $41.88 million. This is considered a Sub-Micro Cap stock.
Last quarter Petmed Express reported $43 million in Revenue and -$.19 earnings per share. This beat revenue expectation by $34 million and missed earnings estimates by -$.01.
In the last 3 years, PETS traded as high as $15.08 and as low as $1.57.
The top ETF exchange traded funds that PETS belongs to (by Net Assets): VTI, VXF, FSCC, BSVO, IWC.
PETS has underperformed the market in the last year with a price return of -44.2% while the SPY ETF gained +20.0%. PETS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.5% and -2.0%, respectively, while the SPY returned +5.4% and +0.3%, respectively.
PETS support price is $1.91 and resistance is $2.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PETS shares will trade within this expected range on the day.